Biotech Values

[genisi]

PLX

Just heard their CEO talk and he said they are awaiting EU approval for Elelyso despite of Shire's orphan exclusivity there (for background see #msg-72258978). Another note is they are planning to enter the clinic with PRX-106 (anti-TNF fusion protein) later this year, despite of Amgen's new patent related to Enbrel.